pharma sector: Biosimilars offering a great opportunity in g

pharma sector: Biosimilars offering a great opportunity in growing market: Kewal Handa

The prices have really been coming down in terms of raw materials and particularly in APIs. There is a lot of stability there. China are also now trying to align themselves to the global market requirements and they are also very keen to see that their factories start producing at the scale they were doing prior to COVID.

Related Keywords

India , China , Lucknow , Uttar Pradesh , Kewal Handa , Pfizer , Cipla , Novartis , Indian School Of Business , Offering College , Astrazeneca , Leadership Excellence ,

© 2025 Vimarsana